Inspection Report Form FDA 483 issued June 10, 2025Types of Products Made: Sterile compounded drug products, including semaglutide injection and hormone health treatments sold to Hims & Hers Telehealth customers (see Essential Extras below)FDA Warning: MedisourceRx failed to submit adverse event reports to the FDA within the required timeframe
One of the first reports offering real-world data on GLP-1 efficacy found that people using the medicines had lost an average of about 1.4% of their starting body weight after three months, which steadily increased to an average of about 3% weight loss after a full year on the treatment
Early detection is key, so if youre experiencing symptoms like fatigue, numbness, or unexplained weight loss, its wise to get tested
This targeted distribution contributes to the favorable side effect profile relative to systemic weight loss interventions like stimulants
Bring the eggs to a rolling boil over high heat after about 10-12 minutes
The documented research dose is ~2.33 mg of total blend per administration, which for a 70 mg vial reconstituted in 3 mL equals 0.10 mL, or 10 units on a U-100 syringe